METHODS AND DEVICES FOR DETERMINING A GUEST STRUCTURE ON A HOST STRUCTURE

    公开(公告)号:WO2019151864A1

    公开(公告)日:2019-08-08

    申请号:PCT/NL2019/050071

    申请日:2019-02-05

    Abstract: One aspect of this disclosure relates to a method for determining a presence of at least one guest structure at a host structure. The method comprises a light-sensitive system receiving light from the host structure. The host structure hosts one or more optically active entities at at least one part of the host structure. Herein, the at least one part does not host the at least one guest structure. Furthermore, the optically active entities cause light emission from said at least one part. The method also comprises the light-sensitive system outputting a signal based on the received light. The method further comprises determining a light value based on the output signal. The light value indicates an amount of light from the host structure being incident on the light- sensitive system. The method also comprises determining on the basis of the light value at least one of a quantity and a position of the at least one guest structure at the host structure.

    VERAPAMIL LIKE COMPOUNDS
    148.
    发明申请
    VERAPAMIL LIKE COMPOUNDS 审中-公开
    VERAPAMIL类化合物

    公开(公告)号:WO2014098593A1

    公开(公告)日:2014-06-26

    申请号:PCT/NL2013050925

    申请日:2013-12-19

    CPC classification number: A61K31/277 A61K51/04 C07B59/001

    Abstract: The invention is directed to a compound, a salt or a solvate thereof according to (I) wherein R1 is an optionally branched fluoroalkyl group or [18F]fluoroalkyl group, R2, R3, R4 and R5 are eacn independently a methyl, [3H]methyl, fluoroalkyl or [18F]fluoroalkyl group, and R6 is a (R)-cyano group or a (S)-cyano group; or wherein R1 is a methyl group, and R3 is a R3 is a fluoroalkyl group or a [18F]fluoroalkyl group, R2, R4 and R5 are each independently a methyl, [3H]methyl, fluoroalkyl or [18F]fluoroalkyl group, and R6 is a (R)-cyano group or a (S)-cyano group; or wherein if R1 is hydrogen, at least one of R2, R3, R4 is an optionally branched fluoroalkyl group or [18F]fluoroalkyl group.

    Abstract translation: 本发明涉及根据(I)的化合物,其盐或溶剂合物,其中R 1是任选支链的氟代烷基或[18 F]氟代烷基,R 2,R 3,R 4和R 5独立地是甲基,[3 H] 甲基,氟代烷基或[18 F]氟烷基,R 6为(R) - 氰基或(S) - 氰基; 或其中R 1为甲基,R 3为R 3为氟烷基或[18 F]氟代烷基,R 2,R 4和R 5各自独立地为甲基,[3 H]甲基,氟代烷基或[18 F]氟代烷基,和 R6是(R) - 氰基或(S) - 氰基; 或其中如果R 1是氢,则R 2,R 3,R 4中的至少一个是任选支链的氟代烷基或[18 F]氟代烷基。

    METHOD FOR DETERMINING TOXICITY
    149.
    发明申请
    METHOD FOR DETERMINING TOXICITY 审中-公开
    确定毒性的方法

    公开(公告)号:WO2013151440A3

    公开(公告)日:2014-01-09

    申请号:PCT/NL2013050256

    申请日:2013-04-05

    CPC classification number: C12Q1/689 C12Q2600/142 C12Q2600/158

    Abstract: A method for determining toxicity of a sample, particularly a soil sample suspected of containing polycyclic aromatic hydrocarbon pollutants, is provided. The method allows for quantification of toxicity levels based on gene expression profiling of a test organism, for example Folsomia candida,exposed to the sample.

    Abstract translation: 提供了一种确定样品毒性的方法,特别是怀疑含有多环芳烃污染物的土壤样品。 该方法允许基于暴露于样品的测试生物(例如,假丝酵母​​菌)的基因表达谱来定量毒性水平。

    miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS
    150.
    发明申请
    miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS 审中-公开
    miRNA在血清脑膜障碍患者中的​​作用

    公开(公告)号:WO2013070079A8

    公开(公告)日:2013-10-24

    申请号:PCT/NL2012050793

    申请日:2012-11-09

    CPC classification number: C12Q1/6809 C12Q2600/178

    Abstract: The blood-brain barrier (BBB) separates the blood and the central nervous system (CNS). Here it is disclosed that blood-brain barrier function can be increased with particular nucleic acid sequences, in particular in patients suffering from or diagnosed with Multiple Sclerosis. The use of compounds comprising such nucleic acid sequences for increasing blood-brain barrier function is described.

    Abstract translation: 血脑屏障(BBB)分离血液和中枢神经系统(CNS)。 这里公开了可以使用特定的核酸序列,特别是患有或诊断为多发性硬化症的患者来增加血脑屏障功能。 描述了包含这种核酸序列的化合物用于增加血脑屏障功能的用途。

Patent Agency Ranking